Syncona's Freeline files IPO registration document
Syncona Limited NPV
123.40p
16:40 18/04/24
-0.48%
-0.60p
Healthcare investor Syncona said its portfolio company Freeline Therapeutics has filed a registration statement with the US Securities and Exchange Commission for a proposed initial public offering (IPO).
Equity Investment Instruments
11,533.52
17:14 18/04/24
0.42%
48.68
FTSE 250
19,450.67
17:14 18/04/24
n/a
n/a
FTSE 350
4,334.00
17:14 18/04/24
n/a
n/a
FTSE All-Share
4,290.02
16:54 18/04/24
n/a
n/a
Syncona said the IPO of American Depositary Shares, each representing one ordinary share, would be listed the Nasdaq Global Select Market. The number of ADSs to be offered and the pricing terms for the proposed IPO have not yet been determined, it added.
Freeline last week raised $120m to support the launch of a clinical trial of its lead gene therapy candidate for the treatment of haemophilia B.